MX9605327A - Uso de ciertos derivados de acido metanbisfosfonico para prevenir el aflojamiento de las protesis y la emigracion de las protesis. - Google Patents

Uso de ciertos derivados de acido metanbisfosfonico para prevenir el aflojamiento de las protesis y la emigracion de las protesis.

Info

Publication number
MX9605327A
MX9605327A MX9605327A MX9605327A MX9605327A MX 9605327 A MX9605327 A MX 9605327A MX 9605327 A MX9605327 A MX 9605327A MX 9605327 A MX9605327 A MX 9605327A MX 9605327 A MX9605327 A MX 9605327A
Authority
MX
Mexico
Prior art keywords
prosthesis
acid derivatives
migration
loosening
prevent
Prior art date
Application number
MX9605327A
Other languages
English (en)
Other versions
MXPA96005327A (es
Inventor
Allen E Goodship
John Kenwright
Jonathan Green
Original Assignee
Novartis Ag Tambien Denominada
Y O Novartis Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag Tambien Denominada, Y O Novartis Inc filed Critical Novartis Ag Tambien Denominada
Priority claimed from PCT/IB1995/000288 external-priority patent/WO1995030421A1/en
Publication of MXPA96005327A publication Critical patent/MXPA96005327A/es
Publication of MX9605327A publication Critical patent/MX9605327A/es

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

La invencion se refiere al uso de ciertos derivados de ácido metanbisfosfonicos (para la fabricacion de una composicion farmacéutica), para la prevencion y el tratamiento de alojamiento de protesis y emigracion de protesis en mamíferos, incluyendo al hombre.
MX9605327A 1995-04-24 1995-04-24 Uso de ciertos derivados de acido metanbisfosfonico para prevenir el aflojamiento de las protesis y la emigracion de las protesis. MX9605327A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9408775.6 1994-05-04
PCT/IB1995/000288 WO1995030421A1 (en) 1994-05-04 1995-04-24 Use of certain methanebisphosphonic acid derivatives to prevent prosthesis loosening and prosthesis migration

Publications (2)

Publication Number Publication Date
MXPA96005327A MXPA96005327A (es) 1998-02-01
MX9605327A true MX9605327A (es) 1998-02-28

Family

ID=39165081

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9605327A MX9605327A (es) 1995-04-24 1995-04-24 Uso de ciertos derivados de acido metanbisfosfonico para prevenir el aflojamiento de las protesis y la emigracion de las protesis.

Country Status (1)

Country Link
MX (1) MX9605327A (es)

Similar Documents

Publication Publication Date Title
GB9408775D0 (en) Use of certain methanebisphosphonic acid derivatives to prevent prothesis loosening and prothesis migration
AU7449598A (en) Medicinal composition for prevention or treatment of hepatopathy
BG103793A (en) COMBINED THERAPY USING BENZOTHIAPINS INHIBITING THE ILEAL BILE ACID TRANSPORT AND HMG Co-A REDUCTASE INHIBITORS
UA42747C2 (uk) Похідні пептиду,фармацевтична композиція та спосіб стимулювання секреції гормону росту
CA2289717A1 (en) Novel therapy for constipation
MX9704030A (es) 1,1-dioxidos de 2-heterocicliloxi y tiometil-1,2,5-tiadiazolidin-3-ona y composiciones y metodo de uso de los mismos.
MX9709238A (es) Formulaciones farmaceuticas y de dieta para la profilaxis y tratamiento de trastornos gastrointestinales.
MY111260A (en) Pharmaceutical composition for the treatment of nicotine dependence
SI0785948T1 (en) Analogs of keratinocyte growth factor
PL310474A1 (en) Application of rilusole in treating neuro-aids diseases
ES2160643T3 (es) Composiciones que contienen g-csf y proteina de union al tnf.
PL338673A1 (en) Application of fanquinone in treating alzheimer disease
MX9704034A (es) Derivados y composiciones de 1,1-dioxido de 2-arilcarboniloximetil-1,2,5-tiadiazolidin-3-ona substituido y metodo de uso.
MY129782A (en) Novel medical use
NZ326345A (en) Composition containing diosgenin
EP0744176A3 (en) Methods for inhibiting bone loss
LT96093A (en) The active ingredient of pharmaceutical composition for treating aphtae and stomatitis
MX9803610A (es) Utilizacion de flupirtina para la profilaxis y la terapia de enfermedades que van a compañadas de un deterioro del sistema celular hermatopoyetico.
EP0743068A3 (en) Composition for inhibiting bone loss containing vanadyl sulfate
MX9605327A (es) Uso de ciertos derivados de acido metanbisfosfonico para prevenir el aflojamiento de las protesis y la emigracion de las protesis.
IL116827A (en) Use of 3,4-diphenyl chromans for the preparation of pharmaceutical compositions for vasodilatory treatment and prophylaxis
CA2183764A1 (en) Use of certain methanebisphosphonic acid derivatives to prevent prosthesis loosening and prosthesis migration
NZ268039A (en) Use of efaroxan in treating parkinson's disease
MD1296F1 (en) The Nicolau method of treatment of the lichen planus
ITLE920006V0 (it) Pannolino in cotone 100% fibra naturale (ecologico) per la prevenzionee cura della displasia congenita dell'anca.

Legal Events

Date Code Title Description
FG Grant or registration
GD Licence granted
MM Annulment or lapse due to non-payment of fees